Table of Contents 1 Somatostatin Market Overview 1.1 Product Overview and Scope of Somatostatin 1.2 Somatostatin Segment by Type 1.2.1 Global Somatostatin Sales Growth Rate Comparison by Type (2021-2026) 1.2.2 0.25 1.2.3 0.75 1.2.4 3 1.3 Somatostatin Segment by Application 1.3.1 Somatostatin Sales Comparison by Application: 2020 VS 2026 1.3.2 Hormonal Disorder 1.3.3 Oncology 1.3.4 Metabolic Disorder 1.3.5 Others 1.4 Global Somatostatin Market Size Estimates and Forecasts 1.4.1 Global Somatostatin Revenue 2015-2026 1.4.2 Global Somatostatin Sales 2015-2026 1.4.3 Somatostatin Market Size by Region: 2020 Versus 2026 2 Global Somatostatin Market Competition by Manufacturers 2.1 Global Somatostatin Sales Market Share by Manufacturers (2015-2020) 2.2 Global Somatostatin Revenue Share by Manufacturers (2015-2020) 2.3 Global Somatostatin Average Price by Manufacturers (2015-2020) 2.4 Manufacturers Somatostatin Manufacturing Sites, Area Served, Product Type 2.5 Somatostatin Market Competitive Situation and Trends 2.5.1 Somatostatin Market Concentration Rate 2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue 2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 2.6 Manufacturers Mergers & Acquisitions, Expansion Plans 2.7 Primary Interviews with Key Somatostatin Players (Opinion Leaders) 3 Somatostatin Retrospective Market Scenario by Region 3.1 Global Somatostatin Retrospective Market Scenario in Sales by Region: 2015-2020 3.2 Global Somatostatin Retrospective Market Scenario in Revenue by Region: 2015-2020 3.3 North America Somatostatin Market Facts & Figures by Country 3.3.1 North America Somatostatin Sales by Country 3.3.2 North America Somatostatin Sales by Country 3.3.3 U.S. 3.3.4 Canada 3.4 Europe Somatostatin Market Facts & Figures by Country 3.4.1 Europe Somatostatin Sales by Country 3.4.2 Europe Somatostatin Sales by Country 3.4.3 Germany 3.4.4 France 3.4.5 U.K. 3.4.6 Italy 3.4.7 Russia 3.5 Asia Pacific Somatostatin Market Facts & Figures by Region 3.5.1 Asia Pacific Somatostatin Sales by Region 3.5.2 Asia Pacific Somatostatin Sales by Region 3.5.3 China 3.5.4 Japan 3.5.5 South Korea 3.5.6 India 3.5.7 Australia 3.5.8 Taiwan 3.5.9 Indonesia 3.5.10 Thailand 3.5.11 Malaysia 3.5.12 Philippines 3.5.13 Vietnam 3.6 Latin America Somatostatin Market Facts & Figures by Country 3.6.1 Latin America Somatostatin Sales by Country 3.6.2 Latin America Somatostatin Sales by Country 3.6.3 Mexico 3.6.3 Brazil 3.6.3 Argentina 3.7 Middle East and Africa Somatostatin Market Facts & Figures by Country 3.7.1 Middle East and Africa Somatostatin Sales by Country 3.7.2 Middle East and Africa Somatostatin Sales by Country 3.7.3 Turkey 3.7.4 Saudi Arabia 3.7.5 U.A.E 4 Global Somatostatin Historic Market Analysis by Type 4.1 Global Somatostatin Sales Market Share by Type (2015-2020) 4.2 Global Somatostatin Revenue Market Share by Type (2015-2020) 4.3 Global Somatostatin Price Market Share by Type (2015-2020) 4.4 Global Somatostatin Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End 5 Global Somatostatin Historic Market Analysis by Application 5.1 Global Somatostatin Sales Market Share by Application (2015-2020) 5.2 Global Somatostatin Revenue Market Share by Application (2015-2020) 5.3 Global Somatostatin Price by Application (2015-2020) 6 Company Profiles and Key Figures in Somatostatin Business 6.1 Merck (Schweiz) AG 6.1.1 Corporation Information 6.1.2 Merck (Schweiz) AG Description, Business Overview and Total Revenue 6.1.3 Merck (Schweiz) AG Somatostatin Sales, Revenue and Gross Margin (2015-2020) 6.1.4 Merck (Schweiz) AG Products Offered 6.1.5 Merck (Schweiz) AG Recent Development 6.2 SANOFI-AVENTIS FRANCE 6.2.1 SANOFI-AVENTIS FRANCE Somatostatin Production Sites and Area Served 6.2.2 SANOFI-AVENTIS FRANCE Description, Business Overview and Total Revenue 6.2.3 SANOFI-AVENTIS FRANCE Somatostatin Sales, Revenue and Gross Margin (2015-2020) 6.2.4 SANOFI-AVENTIS FRANCE Products Offered 6.2.5 SANOFI-AVENTIS FRANCE Recent Development 6.3 Lyomark Pharma GmbH 6.3.1 Lyomark Pharma GmbH Somatostatin Production Sites and Area Served 6.3.2 Lyomark Pharma GmbH Description, Business Overview and Total Revenue 6.3.3 Lyomark Pharma GmbH Somatostatin Sales, Revenue and Gross Margin (2015-2020) 6.3.4 Lyomark Pharma GmbH Products Offered 6.3.5 Lyomark Pharma GmbH Recent Development 6.4 ALFA WASSERMANN S.p.A. 6.4.1 ALFA WASSERMANN S.p.A. Somatostatin Production Sites and Area Served 6.4.2 ALFA WASSERMANN S.p.A. Description, Business Overview and Total Revenue 6.4.3 ALFA WASSERMANN S.p.A. Somatostatin Sales, Revenue and Gross Margin (2015-2020) 6.4.4 ALFA WASSERMANN S.p.A. Products Offered 6.4.5 ALFA WASSERMANN S.p.A. Recent Development 6.5 Polypeptide Laboratories, Inc 6.5.1 Polypeptide Laboratories, Inc Somatostatin Production Sites and Area Served 6.5.2 Polypeptide Laboratories, Inc Description, Business Overview and Total Revenue 6.5.3 Polypeptide Laboratories, Inc Somatostatin Sales, Revenue and Gross Margin (2015-2020) 6.5.4 Polypeptide Laboratories, Inc Products Offered 6.5.5 Polypeptide Laboratories, Inc Recent Development 6.6 SAMARTH 6.6.1 SAMARTH Somatostatin Production Sites and Area Served 6.6.2 SAMARTH Description, Business Overview and Total Revenue 6.6.3 SAMARTH Somatostatin Sales, Revenue and Gross Margin (2015-2020) 6.6.4 SAMARTH Products Offered 6.6.5 SAMARTH Recent Development 6.7 UBPL 6.6.1 UBPL Somatostatin Production Sites and Area Served 6.6.2 UBPL Description, Business Overview and Total Revenue 6.6.3 UBPL Somatostatin Sales, Revenue and Gross Margin (2015-2020) 6.4.4 UBPL Products Offered 6.7.5 UBPL Recent Development 6.8 HYBIO 6.8.1 HYBIO Somatostatin Production Sites and Area Served 6.8.2 HYBIO Description, Business Overview and Total Revenue 6.8.3 HYBIO Somatostatin Sales, Revenue and Gross Margin (2015-2020) 6.8.4 HYBIO Products Offered 6.8.5 HYBIO Recent Development 6.9 TianTaiShan 6.9.1 TianTaiShan Somatostatin Production Sites and Area Served 6.9.2 TianTaiShan Description, Business Overview and Total Revenue 6.9.3 TianTaiShan Somatostatin Sales, Revenue and Gross Margin (2015-2020) 6.9.4 TianTaiShan Products Offered 6.9.5 TianTaiShan Recent Development 6.10 Yangtze River 6.10.1 Yangtze River Somatostatin Production Sites and Area Served 6.10.2 Yangtze River Description, Business Overview and Total Revenue 6.10.3 Yangtze River Somatostatin Sales, Revenue and Gross Margin (2015-2020) 6.10.4 Yangtze River Products Offered 6.10.5 Yangtze River Recent Development 6.11 Siyao 6.11.1 Siyao Somatostatin Production Sites and Area Served 6.11.2 Siyao Somatostatin Description, Business Overview and Total Revenue 6.11.3 Siyao Somatostatin Sales, Revenue and Gross Margin (2015-2020) 6.11.4 Siyao Products Offered 6.11.5 Siyao Recent Development 6.12 Shuangcheng 6.12.1 Shuangcheng Somatostatin Production Sites and Area Served 6.12.2 Shuangcheng Somatostatin Description, Business Overview and Total Revenue 6.12.3 Shuangcheng Somatostatin Sales, Revenue and Gross Margin (2015-2020) 6.12.4 Shuangcheng Products Offered 6.12.5 Shuangcheng Recent Development 6.13 Hainan Zhonghe 6.13.1 Hainan Zhonghe Somatostatin Production Sites and Area Served 6.13.2 Hainan Zhonghe Somatostatin Description, Business Overview and Total Revenue 6.13.3 Hainan Zhonghe Somatostatin Sales, Revenue and Gross Margin (2015-2020) 6.13.4 Hainan Zhonghe Products Offered 6.13.5 Hainan Zhonghe Recent Development 6.14 SL PHARM 6.14.1 SL PHARM Somatostatin Production Sites and Area Served 6.14.2 SL PHARM Somatostatin Description, Business Overview and Total Revenue 6.14.3 SL PHARM Somatostatin Sales, Revenue and Gross Margin (2015-2020) 6.14.4 SL PHARM Products Offered 6.14.5 SL PHARM Recent Development 6.15 Wuhan Hualong 6.15.1 Wuhan Hualong Somatostatin Production Sites and Area Served 6.15.2 Wuhan Hualong Somatostatin Description, Business Overview and Total Revenue 6.15.3 Wuhan Hualong Somatostatin Sales, Revenue and Gross Margin (2015-2020) 6.15.4 Wuhan Hualong Products Offered 6.15.5 Wuhan Hualong Recent Development 6.16 Qingdao Guoda 6.16.1 Qingdao Guoda Somatostatin Production Sites and Area Served 6.16.2 Qingdao Guoda Somatostatin Description, Business Overview and Total Revenue 6.16.3 Qingdao Guoda Somatostatin Sales, Revenue and Gross Margin (2015-2020) 6.16.4 Qingdao Guoda Products Offered 6.16.5 Qingdao Guoda Recent Development 6.17 Chengdu Shengnuo 6.17.1 Chengdu Shengnuo Somatostatin Production Sites and Area Served 6.17.2 Chengdu Shengnuo Somatostatin Description, Business Overview and Total Revenue 6.17.3 Chengdu Shengnuo Somatostatin Sales, Revenue and Gross Margin (2015-2020) 6.17.4 Chengdu Shengnuo Products Offered 6.17.5 Chengdu Shengnuo Recent Development 6.18 Longjin 6.18.1 Longjin Somatostatin Production Sites and Area Served 6.18.2 Longjin Somatostatin Description, Business Overview and Total Revenue 6.18.3 Longjin Somatostatin Sales, Revenue and Gross Margin (2015-2020) 6.18.4 Longjin Products Offered 6.18.5 Longjin Recent Development 7 Somatostatin Manufacturing Cost Analysis 7.1 Somatostatin Key Raw Materials Analysis 7.1.1 Key Raw Materials 7.1.2 Key Raw Materials Price Trend 7.1.3 Key Suppliers of Raw Materials 7.2 Proportion of Manufacturing Cost Structure 7.3 Manufacturing Process Analysis of Somatostatin 7.4 Somatostatin Industrial Chain Analysis 8 Marketing Channel, Distributors and Customers 8.1 Marketing Channel 8.2 Somatostatin Distributors List 8.3 Somatostatin Customers 9 Market Dynamics 9.1 Market Trends 9.2 Opportunities and Drivers 9.3 Challenges 9.4 Porter's Five Forces Analysis 10 Global Market Forecast 10.1 Global Somatostatin Market Estimates and Projections by Type 10.1.1 Global Forecasted Sales of Somatostatin by Type (2021-2026) 10.1.2 Global Forecasted Revenue of Somatostatin by Type (2021-2026) 10.2 Somatostatin Market Estimates and Projections by Application 10.2.1 Global Forecasted Sales of Somatostatin by Application (2021-2026) 10.2.2 Global Forecasted Revenue of Somatostatin by Application (2021-2026) 10.3 Somatostatin Market Estimates and Projections by Region 10.3.1 Global Forecasted Sales of Somatostatin by Region (2021-2026) 10.3.2 Global Forecasted Revenue of Somatostatin by Region (2021-2026) 10.4 North America Somatostatin Estimates and Projections (2021-2026) 10.5 Europe Somatostatin Estimates and Projections (2021-2026) 10.6 Asia Pacific Somatostatin Estimates and Projections (2021-2026) 10.7 Latin America Somatostatin Estimates and Projections (2021-2026) 10.8 Middle East and Africa Somatostatin Estimates and Projections (2021-2026) 11 Research Finding and Conclusion 12 Methodology and Data Source 12.1 Methodology/Research Approach 12.1.1 Research Programs/Design 12.1.2 Market Size Estimation 12.1.3 Market Breakdown and Data Triangulation 12.2 Data Source 12.2.1 Secondary Sources 12.2.2 Primary Sources 12.3 Author List 12.4 Disclaimer

List of Tables Table 1. Global Somatostatin Sales (K Pcs) Growth Rate Comparison by Type (2015-2026) Table 2. Global Somatostatin Sales (K Pcs) Comparison by Application: 2020 VS 2026 Table 3. Global Somatostatin Market Size by Type (K Pcs) (US$ Million) (2020 VS 2026) Table 4. Global Key Somatostatin Manufacturers Covered in This Study Table 5. Global Somatostatin Sales (K Pcs) by Manufacturers (2015-2020) Table 6. Global Somatostatin Sales Share by Manufacturers (2015-2020) Table 7. Global Somatostatin Revenue (Million USD) by Manufacturers (2015-2020) Table 8. Global Somatostatin Revenue Share by Manufacturers (2015-2020) Table 9. Global Market Somatostatin Average Price (USD/Pcs) of Key Manufacturers (2015-2020) Table 10. Manufacturers Somatostatin Sales Sites and Area Served Table 11. Manufacturers Somatostatin Product Types Table 12. Global Somatostatin Manufacturers Market Concentration Ratio (CR5 and HHI) Table 13. Global Somatostatin by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Somatostatin as of 2019) Table 14.Manufacturers Mergers & Acquisitions, Expansion Plans Table 15. Main Points Interviewed from Key Somatostatin Players Table 16. Global Somatostatin Sales (K Pcs) by Region (2015-2020) Table 17. Global Somatostatin Sales Market Share by Region (2015-2020) Table 18. Global Somatostatin Revenue (Million US$) by Region (2015-2020) Table 19. Global Somatostatin Revenue Market Share by Region (2015-2020) Table 20. North America Somatostatin Sales by Country (2015-2020) (K Pcs) Table 21. North America Somatostatin Sales Market Share by Country (2015-2020) Table 22. North America Somatostatin Revenue by Country (2015-2020) (US$ Million) Table 23. North America Somatostatin Revenue Market Share by Country (2015-2020) Table 24. Europe Somatostatin Sales by Country (2015-2020) (K Pcs) Table 25. Europe Somatostatin Sales Market Share by Country (2015-2020) Table 26. Europe Somatostatin Revenue by Country (2015-2020) (US$ Million) Table 27. Europe Somatostatin Revenue Market Share by Country (2015-2020) Table 28. Asia Pacific Somatostatin Sales by Region (2015-2020) (K Pcs) Table 29. Asia Pacific Somatostatin Sales Market Share by Region (2015-2020) Table 30. Asia Pacific Somatostatin Revenue by Region (2015-2020) (US$ Million) Table 31. Asia Pacific Somatostatin Revenue Market Share by Region (2015-2020) Table 32. Latin America Somatostatin Sales by Country (2015-2020) (K Pcs) Table 33. Latin America Somatostatin Sales Market Share by Country (2015-2020) Table 34. Latin America Somatostatin Revenue by Country (2015-2020) (US$ Million) Table 35. Latin America Somatostatin Revenue Market Share by Country (2015-2020) Table 36. Middle East and Africa Somatostatin Sales by Country (2015-2020) (K Pcs) Table 37. Middle East and Africa Somatostatin Sales Market Share by Country (2015-2020) Table 38. Middle East and Africa Somatostatin Revenue by Country (2015-2020) (US$ Million) Table 39. Middle East and Africa Somatostatin Revenue Market Share by Country (2015-2020) Table 40. Global Somatostatin Sales (K Pcs) by Type (2015-2020) Table 41. Global Somatostatin Sales Share by Type (2015-2020) Table 42. Global Somatostatin Revenue (Million US$) by Type (2015-2020) Table 43. Global Somatostatin Revenue Share by Type (2015-2020) Table 44. Global Somatostatin Price (USD/Pcs) by Type (2015-2020) Table 45. Global Somatostatin Sales (K Pcs) by Application (2015-2020) Table 46. Global Somatostatin Sales Market Share by Application (2015-2020) Table 47. Global Somatostatin Sales Growth Rate by Application (2015-2020) Table 48. Merck (Schweiz) AG Somatostatin Corporation Information Table 49. Merck (Schweiz) AG Description and Business Overview Table 50. Merck (Schweiz) AG Somatostatin Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020) Table 51. Merck (Schweiz) AG Main Product Table 52. Merck (Schweiz) AG Recent Development Table 53. SANOFI-AVENTIS FRANCE Somatostatin Corporation Information Table 54. SANOFI-AVENTIS FRANCE Corporation Information Table 55. SANOFI-AVENTIS FRANCE Somatostatin Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020) Table 56. SANOFI-AVENTIS FRANCE Main Product Table 57. SANOFI-AVENTIS FRANCE Recent Development Table 58. Lyomark Pharma GmbH Somatostatin Corporation Information Table 59. Lyomark Pharma GmbH Corporation Information Table 60. Lyomark Pharma GmbH Somatostatin Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020) Table 61. Lyomark Pharma GmbH Main Product Table 62. Lyomark Pharma GmbH Recent Development Table 63. ALFA WASSERMANN S.p.A. Somatostatin Corporation Information Table 64. ALFA WASSERMANN S.p.A. Corporation Information Table 65. ALFA WASSERMANN S.p.A. Somatostatin Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020) Table 66. ALFA WASSERMANN S.p.A. Main Product Table 67. ALFA WASSERMANN S.p.A. Recent Development Table 68. Polypeptide Laboratories, Inc Somatostatin Corporation Information Table 69. Polypeptide Laboratories, Inc Corporation Information Table 70. Polypeptide Laboratories, Inc Somatostatin Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020) Table 71. Polypeptide Laboratories, Inc Main Product Table 72. Polypeptide Laboratories, Inc Recent Development Table 73. SAMARTH Somatostatin Corporation Information Table 74. SAMARTH Corporation Information Table 75. SAMARTH Somatostatin Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020) Table 76. SAMARTH Main Product Table 77. SAMARTH Recent Development Table 78. UBPL Somatostatin Corporation Information Table 79. UBPL Corporation Information Table 80. UBPL Somatostatin Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020) Table 81. UBPL Main Product Table 82. UBPL Recent Development Table 83. HYBIO Somatostatin Corporation Information Table 84. HYBIO Corporation Information Table 85. HYBIO Somatostatin Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020) Table 86. HYBIO Main Product Table 87. HYBIO Recent Development Table 88. TianTaiShan Somatostatin Corporation Information Table 89. TianTaiShan Corporation Information Table 90. TianTaiShan Somatostatin Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020) Table 91. TianTaiShan Main Product Table 92. TianTaiShan Recent Development Table 93. Yangtze River Somatostatin Corporation Information Table 94. Yangtze River Corporation Information Table 95. Yangtze River Somatostatin Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020) Table 96. Yangtze River Main Product Table 97. Yangtze River Recent Development Table 98. Siyao Somatostatin Corporation Information Table 99. Siyao Corporation Information Table 100. Siyao Somatostatin Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020) Table 101. Siyao Main Product Table 102. Siyao Recent Development Table 103. Shuangcheng Somatostatin Corporation Information Table 104. Shuangcheng Corporation Information Table 105. Shuangcheng Somatostatin Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020) Table 106. Shuangcheng Main Product Table 107. Shuangcheng Recent Development Table 108. Hainan Zhonghe Somatostatin Corporation Information Table 109. Hainan Zhonghe Corporation Information Table 110. Hainan Zhonghe Somatostatin Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020) Table 111. Hainan Zhonghe Main Product Table 112. Hainan Zhonghe Recent Development Table 113. SL PHARM Somatostatin Corporation Information Table 114. SL PHARM Corporation Information Table 115. SL PHARM Somatostatin Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020) Table 116. SL PHARM Main Product Table 117. SL PHARM Recent Development Table 118. Wuhan Hualong Somatostatin Corporation Information Table 119. Wuhan Hualong Corporation Information Table 120. Wuhan Hualong Somatostatin Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020) Table 121. Wuhan Hualong Main Product Table 122. Wuhan Hualong Recent Development Table 123. Qingdao Guoda Somatostatin Corporation Information Table 124. Qingdao Guoda Corporation Information Table 125. Qingdao Guoda Somatostatin Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020) Table 126. Qingdao Guoda Main Product Table 127. Qingdao Guoda Recent Development Table 128. Chengdu Shengnuo Somatostatin Corporation Information Table 129. Chengdu Shengnuo Corporation Information Table 130. Chengdu Shengnuo Somatostatin Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020) Table 131. Chengdu Shengnuo Main Product Table 132. Chengdu Shengnuo Recent Development Table 133. Longjin Somatostatin Corporation Information Table 134. Longjin Corporation Information Table 135. Longjin Somatostatin Sales (K Pcs), Revenue (Million US$), Price (USD/Pcs) and Gross Margin (2015-2020) Table 136. Longjin Main Product Table 137. Longjin Recent Development Table 138. Sales Base and Market Concentration Rate of Raw Material Table 139. Key Suppliers of Raw Materials Table 140. Somatostatin Distributors List Table 141. Somatostatin Customers List Table 142. Market Key Trends Table 143. Key Opportunities and Drivers: Impact Analysis (2021-2026) Table 144. Key Challenges Table 145. Global Somatostatin Sales (K Pcs) Forecast by Type (2021-2026) Table 146. Global Somatostatin Sales Market Share Forecast by Type (2021-2026) Table 147. Global Somatostatin Revenue (Million US$) Forecast by Type (2021-2026) Table 148. Global Somatostatin Revenue (Million US$) Market Share Forecast by Type (2021-2026) Table 149. Global Somatostatin Sales (K Pcs) Forecast by Application (2021-2026) Table 150. Global Somatostatin Revenue (Million US$) Forecast by Application (2021-2026) Table 151. Global Somatostatin Sales (K Pcs) Forecast by Region (2021-2026) Table 152. Global Somatostatin Sales Market Share Forecast by Region (2021-2026) Table 153. Global Somatostatin Revenue Forecast by Region (2021-2026) (US$ Million) Table 154. Global Somatostatin Revenue Market Share Forecast by Region (2021-2026) Table 155. Research Programs/Design for This Report Table 156. Key Data Information from Secondary Sources Table 157. Key Data Information from Primary Sources List of Figures Figure 1. Picture of Somatostatin Figure 2. Global Somatostatin Sales Market Share by Type: 2020 VS 2026 Figure 3. 0.25 Product Picture Figure 4. 0.75 Product Picture Figure 5. 3 Product Picture Figure 6. Global Somatostatin Consumption Market Share by Application: 2020 VS 2026 Figure 7. Hormonal Disorder Figure 8. Oncology Figure 9. Metabolic Disorder Figure 10. Others Figure 11. Global Somatostatin Market Size 2015-2026 (US$ Million) Figure 12. Global Somatostatin Sales Capacity (K Pcs) (2015-2026) Figure 13. Global Somatostatin Market Size Market Share by Region: 2020 Versus 2026 Figure 14. Somatostatin Sales Share by Manufacturers in 2020 Figure 15. Global Somatostatin Revenue Share by Manufacturers in 2019 Figure 16. The Global 5 and 10 Largest Players: Market Share by Somatostatin Revenue in 2019 Figure 17. Somatostatin Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019 Figure 18. Global Somatostatin Sales Market Share by Region (2015-2020) Figure 19. Global Somatostatin Sales Market Share by Region in 2019 Figure 20. Global Somatostatin Revenue Market Share by Region (2015-2020) Figure 21. Global Somatostatin Revenue Market Share by Region in 2019 Figure 22. North America Somatostatin Sales Market Share by Country in 2019 Figure 23. North America Somatostatin Revenue Market Share by Country in 2019 Figure 24. U.S. Somatostatin Sales Growth Rate (2015-2020) (K Pcs) Figure 25. U.S. Somatostatin Revenue Growth Rate (2015-2020) (US$ Million) Figure 26. Canada Somatostatin Sales Growth Rate (2015-2020) (K Pcs) Figure 27. Canada Somatostatin Revenue Growth Rate (2015-2020) (US$ Million) Figure 28. Europe Somatostatin Sales Market Share by Country in 2019 Figure 29. Europe Somatostatin Revenue Market Share by Country in 2019 Figure 30. Germany Somatostatin Sales Growth Rate (2015-2020) (K Pcs) Figure 31. Germany Somatostatin Revenue Growth Rate (2015-2020) (US$ Million) Figure 32. France Somatostatin Sales Growth Rate (2015-2020) (K Pcs) Figure 33. France Somatostatin Revenue Growth Rate (2015-2020) (US$ Million) Figure 34. U.K. Somatostatin Sales Growth Rate (2015-2020) (K Pcs) Figure 35. U.K. Somatostatin Revenue Growth Rate (2015-2020) (US$ Million) Figure 36. Italy Somatostatin Sales Growth Rate (2015-2020) (K Pcs) Figure 37. Italy Somatostatin Revenue Growth Rate (2015-2020) (US$ Million) Figure 38. Russia Somatostatin Sales Growth Rate (2015-2020) (K Pcs) Figure 39. Russia Somatostatin Revenue Growth Rate (2015-2020) (US$ Million) Figure 40. Asia Pacific Somatostatin Sales Market Share by Region in 2019 Figure 41. Asia Pacific Somatostatin Revenue Market Share by Region in 2019 Figure 42. China Somatostatin Sales Growth Rate (2015-2020) (K Pcs) Figure 43. China Somatostatin Revenue Growth Rate (2015-2020) (US$ Million) Figure 44. Japan Somatostatin Sales Growth Rate (2015-2020) (K Pcs) Figure 45. Japan Somatostatin Revenue Growth Rate (2015-2020) (US$ Million) Figure 46. South Korea Somatostatin Sales Growth Rate (2015-2020) (K Pcs) Figure 47. South Korea Somatostatin Revenue Growth Rate (2015-2020) (US$ Million) Figure 48. India Somatostatin Sales Growth Rate (2015-2020) (K Pcs) Figure 49. India Somatostatin Revenue Growth Rate (2015-2020) (US$ Million) Figure 50. Australia Somatostatin Sales Growth Rate (2015-2020) (K Pcs) Figure 51. Australia Somatostatin Revenue Growth Rate (2015-2020) (US$ Million) Figure 52. Taiwan Somatostatin Sales Growth Rate (2015-2020) (K Pcs) Figure 53. Taiwan Somatostatin Revenue Growth Rate (2015-2020) (US$ Million) Figure 54. Indonesia Somatostatin Sales Growth Rate (2015-2020) (K Pcs) Figure 55. Indonesia Somatostatin Revenue Growth Rate (2015-2020) (US$ Million) Figure 56. Thailand Somatostatin Sales Growth Rate (2015-2020) (K Pcs) Figure 57. Thailand Somatostatin Revenue Growth Rate (2015-2020) (US$ Million) Figure 58. Malaysia Somatostatin Sales Growth Rate (2015-2020) (K Pcs) Figure 59. Malaysia Somatostatin Revenue Growth Rate (2015-2020) (US$ Million) Figure 60. Philippines Somatostatin Sales Growth Rate (2015-2020) (K Pcs) Figure 61. Philippines Somatostatin Revenue Growth Rate (2015-2020) (US$ Million) Figure 62. Vietnam Somatostatin Sales Growth Rate (2015-2020) (K Pcs) Figure 63. Vietnam Somatostatin Revenue Growth Rate (2015-2020) (US$ Million) Figure 64. Latin America Somatostatin Sales Market Share by Country in 2019 Figure 65. Latin America Somatostatin Revenue Market Share by Country in 2019 Figure 66. Mexico Somatostatin Sales Growth Rate (2015-2020) (K Pcs) Figure 67. Mexico Somatostatin Revenue Growth Rate (2015-2020) (US$ Million) Figure 68. Brazil Somatostatin Sales Growth Rate (2015-2020) (K Pcs) Figure 69. Brazil Somatostatin Revenue Growth Rate (2015-2020) (US$ Million) Figure 70. Argentina Somatostatin Sales Growth Rate (2015-2020) (K Pcs) Figure 71. Argentina Somatostatin Revenue Growth Rate (2015-2020) (US$ Million) Figure 72. Middle East and Africa Somatostatin Sales Market Share by Country in 2019 Figure 73. Middle East and Africa Somatostatin Revenue Market Share by Country in 2019 Figure 74. Turkey Somatostatin Sales Growth Rate (2015-2020) (K Pcs) Figure 75. Turkey Somatostatin Revenue Growth Rate (2015-2020) (US$ Million) Figure 76. Saudi Arabia Somatostatin Sales Growth Rate (2015-2020) (K Pcs) Figure 77. Saudi Arabia Somatostatin Revenue Growth Rate (2015-2020) (US$ Million) Figure 78. U.A.E Somatostatin Sales Growth Rate (2015-2020) (K Pcs) Figure 79. U.A.E Somatostatin Revenue Growth Rate (2015-2020) (US$ Million) Figure 80. Sales Market Share of Somatostatin by Type (2015-2020) Figure 81. Sales Market Share of Somatostatin by Type in 2019 Figure 82. Revenue Share of Somatostatin by Type (2015-2020) Figure 83. Revenue Market Share of Somatostatin by Type in 2019 Figure 84. Global Somatostatin Sales Growth by Type (2015-2020) (K Pcs) Figure 85. Global Somatostatin Sales Market Share by Application (2015-2020) Figure 86. Global Somatostatin Sales Market Share by Application in 2019 Figure 87. Global Revenue Share of Somatostatin by Application (2015-2020) Figure 88. Global Revenue Share of Somatostatin by Application in 2020 Figure 89. Merck (Schweiz) AG Total Revenue (US$ Million): 2019 Compared with 2018 Figure 90. SANOFI-AVENTIS FRANCE Total Revenue (US$ Million): 2019 Compared with 2018 Figure 91. Lyomark Pharma GmbH Total Revenue (US$ Million): 2019 Compared with 2018 Figure 92. ALFA WASSERMANN S.p.A. Total Revenue (US$ Million): 2019 Compared with 2018 Figure 93. Polypeptide Laboratories, Inc Total Revenue (US$ Million): 2019 Compared with 2018 Figure 94. SAMARTH Total Revenue (US$ Million): 2019 Compared with 2018 Figure 95. UBPL Total Revenue (US$ Million): 2019 Compared with 2018 Figure 96. HYBIO Total Revenue (US$ Million): 2019 Compared with 2018 Figure 97. TianTaiShan Total Revenue (US$ Million): 2019 Compared with 2018 Figure 98. Yangtze River Total Revenue (US$ Million): 2019 Compared with 2018 Figure 99. Siyao Total Revenue (US$ Million): 2019 Compared with 2018 Figure 100. Shuangcheng Total Revenue (US$ Million): 2019 Compared with 2018 Figure 101. Hainan Zhonghe Total Revenue (US$ Million): 2019 Compared with 2018 Figure 102. SL PHARM Total Revenue (US$ Million): 2019 Compared with 2018 Figure 103. Wuhan Hualong Total Revenue (US$ Million): 2019 Compared with 2018 Figure 104. Qingdao Guoda Total Revenue (US$ Million): 2019 Compared with 2018 Figure 105. Chengdu Shengnuo Total Revenue (US$ Million): 2019 Compared with 2018 Figure 106. Longjin Total Revenue (US$ Million): 2019 Compared with 2018 Figure 107. Price Trend of Key Raw Materials Figure 108. Manufacturing Cost Structure of Somatostatin Figure 109. Manufacturing Process Analysis of Somatostatin Figure 110. Somatostatin Industrial Chain Analysis Figure 111. Channels of Distribution Figure 112. Distributors Profiles Figure 113. Porter's Five Forces Analysis Figure 114. North America Somatostatin Sales (K Pcs) and Growth Rate Forecast (2021-2026) Figure 115. North America Somatostatin Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 116. Europe Somatostatin Sales (K Pcs) and Growth Rate Forecast (2021-2026) Figure 117. Europe Somatostatin Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 118. Latin America Somatostatin Sales (K Pcs) and Growth Rate Forecast (2021-2026) Figure 119. Latin America Somatostatin Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 120. Middle East and Africa Somatostatin Sales (K Pcs) and Growth Rate Forecast (2021-2026) Figure 121. Middle East and Africa Somatostatin Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 122. Asia Pacific Somatostatin Sales (K Pcs) and Growth Rate Forecast (2021-2026) Figure 123. Asia Pacific Somatostatin Revenue (Million US$) and Growth Rate Forecast (2021-2026) Figure 124. Bottom-up and Top-down Approaches for This Report Figure 125. Data Triangulation Figure 126. Key Executives Interviewed

Merck (Schweiz) AG SANOFI-AVENTIS FRANCE Lyomark Pharma GmbH ALFA WASSERMANN S.p.A. Polypeptide Laboratories, Inc SAMARTH UBPL HYBIO TianTaiShan Yangtze River Siyao Shuangcheng Hainan Zhonghe SL PHARM Wuhan Hualong Qingdao Guoda Chengdu Shengnuo Longjin